Related Experiment Video
Updated: May 13, 2026

09:32
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Red-light-controlled protein-RNA crosslinking with a genetically encoded furan
Moritz J Schmidt1, Daniel Summerer
1Department of Chemistry and Konstanz Research School Chemical Biology, University of Konstanz, Universitätsstrasse 10, 78457 Konstanz, Germany.
Angewandte Chemie (International Ed. in English)
|March 21, 2013
Summary
Researchers developed a genetically encoded protein-RNA crosslinker controllable with red light. This advancement aids in mapping transient interactions and designing novel RNA-targeted therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Protein-RNA interactions are crucial for cellular functions.
- Mapping transient interactions remains a significant challenge in molecular biology.
- Current methods for studying protein-RNA interactions have limitations in depth and specificity.
Purpose of the Study:
- To develop a novel, genetically encoded crosslinking system for protein-RNA interactions.
- To enable the study of protein-RNA interactions at high penetration depths within biological samples.
- To facilitate the design of new therapeutic strategies targeting RNA.
Main Methods:
- Genetic encoding of a novel protein-RNA crosslinker.
- Utilizing red light for spatiotemporal control of crosslinking.
- Application in biological materials to map protein-RNA interactions.
Main Results:
- Successful genetic encoding of a red-light-controlled protein-RNA crosslinker.
- Demonstrated high penetration depths in biological materials.
- Enabled discovery and mapping of transient protein-RNA interactions.
Conclusions:
- The developed crosslinker offers a powerful tool for studying dynamic protein-RNA interactions.
- Red-light control allows for unprecedented spatial and temporal resolution.
- This technology has potential applications in drug discovery for RNA-targeted therapies.

